FindTrial
Sign In

The role of cardiac sympathetic denervation in Parkinson's disease

Extracranial biomarker in Parkinson’s disease: The role of cardiac sympathetic denervation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010646
Enrollment
150
Registered
2025-06-18
Start date
2021-09-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease, aged above 19

Exclusion criteria

Exclusion criteria: Secondary parkinsonism such as stroke, hydrocephalus or drug-induced which has been confirmed by the investigator

Design outcomes

Primary

MeasureTime frame
The association between nigrostriatal degeneration and cardiac sympathetic denervation—

Secondary

MeasureTime frame
The comparison of cardiac sympathetic denervation assessment tools—

Countries

Korea, Republic of

Contacts

Public ContactSang-Won Yoo

The Catholic University of Korea, Seoul St. Mary's Hospital

hiswy83@gmail.com+82-2-2258-6732

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026